Providing patients with information ... [Nurs Stand. 2009 Jan 28-Feb 3] - PubMed

Pharmacogenetic testing, informed consent and the problem of secondary information. [Bioethics. 2004]
Pharmacogenetic testing, informed consent and the problem of secondary information.
Netzer C, Biller-Andorno N. Bioethics. 2004 Aug; 18(4):344-60.
Pharmacogenetic testing: not as simple as it seems. [Genet Med. 2008]
Pharmacogenetic testing: not as simple as it seems.
Haga SB, Burke W. Genet Med. 2008 Jun; 10(6):391-5.
Review Ancillary risk information and pharmacogenetic tests: social and policy implications. [Pharmacogenomics J. 2008]
Review Ancillary risk information and pharmacogenetic tests: social and policy implications.
Henrikson NB, Burke W, Veenstra DL. Pharmacogenomics J. 2008 Apr; 8(2):85-9. Epub 2007 May 8.
FDA perspectives on pharmacogenetic testing. [Expert Rev Mol Diagn. 2005]
FDA perspectives on pharmacogenetic testing.
Harper CC, Philip R, Robinowitz M, Gutman SI. Expert Rev Mol Diagn. 2005 Sep; 5(5):643-8.
Review Pharmacogenetics: from discovery to patient care. [Am J Health Syst Pharm. 2009]
Review Pharmacogenetics: from discovery to patient care.
Shin J, Kayser SR, Langaee TY. Am J Health Syst Pharm. 2009 Apr 1; 66(7):625-37.

Ethical concerns related to developing pharmacogenomic treatment strategies for addiction. [Addict Sci Clin Pract. 2011]
Ethical concerns related to developing pharmacogenomic treatment strategies for addiction.
Shields AE. Addict Sci Clin Pract. 2011 Jul; 6(1):32-43.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Providing patients with information on pharmacogenetic testing.
Providing patients with information on pharmacogenetic testing.
Nurs Stand. 2009 Jan 28-Feb 3 ;23(21):46-8.

PubMed
Health care provider and consumer awareness, perceptions, and use of direct-to-c...
Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008.
Genet Med. 2009 Aug ;11(8):595.

PubMed
Within a smoking-cessation program, what impact does genetic information on lung...
Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?
Cost Eff Resour Alloc. 2010 Sep 16 ;8:18.

PubMed
Pharmacogenomic testing: relevance in medical practice: why drugs work in some p...
Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.
Cleve Clin J Med. 2011 Apr ;78(4):243-57.

PubMed
Multigenic condition risk assessment in direct-to-consumer genomic services.
Multigenic condition risk assessment in direct-to-consumer genomic services.
Genet Med. 2010 May ;12(5):279-88.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed